{"id":61359,"date":"2021-12-02T12:15:06","date_gmt":"2021-12-02T11:15:06","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=61359"},"modified":"2021-12-03T11:01:47","modified_gmt":"2021-12-03T10:01:47","slug":"vaccino-astrazeneca-team-di-esperti-trova-la-causa-dei-coaguli-killer","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/vaccino-astrazeneca-team-di-esperti-trova-la-causa-dei-coaguli-killer\/","title":{"rendered":"AstraZeneca vaccine, team of experts finds the cause of the &quot;killer&quot; clots"},"content":{"rendered":"<h2>A protein is attracted to a key component of the drug. The research was published in the journal Science Advances<\/h2>\n<p><a href=\"https:\/\/www.tgcom24.mediaset.it\/salute\/vaccino-astrazeneca-team-di-esperti-trova-la-causa-dei-coaguli-killer_42480993-202102k.shtml\" target=\"_blank\" rel=\"noopener\">TGcom24 health \u2013 2 December 2021<\/a><\/p>\n<p>A team of scientists in Wales and the US believe they have found the &#039;trigger&#039; of blood clots <img loading=\"lazy\" decoding=\"async\" class=\"wp-image-61369 alignright\" src=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/12\/7-HIT-Fattore-Protein_PF4_PDB_1f9q.png\" alt=\"\" width=\"402\" height=\"343\" srcset=\"https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/12\/7-HIT-Fattore-Protein_PF4_PDB_1f9q.png 775w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/12\/7-HIT-Fattore-Protein_PF4_PDB_1f9q-300x256.png 300w, https:\/\/www.fedaiisf.it\/wp-content\/uploads\/2021\/12\/7-HIT-Fattore-Protein_PF4_PDB_1f9q-768x656.png 768w\" sizes=\"auto, (max-width: 402px) 100vw, 402px\" \/>extremely rare that were created after the administration of the AstraZeneca vaccine. Under &quot;accuse&quot; one<br \/>\nprotein in the blood that is &quot;attracted&quot; to one of the key components of the vaccine designed in Oxford. The AstraZeneca vaccine due to these rare clots has actually been reduced in use against Covid.<\/p>\n<div id=\"adv-video-article\">The team, reports the BBC, has shown in detail how a protein in the blood is attracted to a key component of the vaccine designed in Oxford, triggering a chain reaction involving the immune system and which can culminate in dangerous clots. Alan Parker, one of the Cardiff University researchers, told the BBC: &quot;What we have is the trigger, the trigger, but there are many steps that need to happen after.&quot;<\/div>\n<p>Research published in the scientific journal Science Advances reveals that the external part of the adenovirus, the viral vector used in the AstraZeneca anti-Covid vaccine, attracts the protein of the <strong>factor four<\/strong> of the platelets like a magnet. To detect this reaction, the scientists used a technique called a cryo-electron microscope that allows for images of the adenovirus at the molecular level.<\/p>\n<p>Professor Alan Parker, one of the Cardiff University researchers told the BBC that it is a difference in magnetic potential between the adenovirus which &quot;has a strongly negative surface area and the on the contrary extremely positive platelet factor four&quot; which triggers the reaction . &quot;While the research isn&#039;t definitive, it does offer interesting insights and AstraZeneca is exploring ways to leverage these findings, as part of our efforts to remove this extremely rare side effect,&quot; a spokesperson for the Anglo-Swedish pharmaceutical company explained. The University of Oxford declined to comment on the research.<\/p>\n<p>According to AstraZeneca, its vaccine has saved more than a million lives worldwide and prevented 50 million cases of Covid. But in the wake of cases of blood clots, albeit rare, the use of this type of vaccine in the world has been reduced, and vaccines that use more modern technology, with messenger RNA, are now used for boosters.<\/p>\n<p>The University of Oxford declined to comment on the research.<\/p>\n<p>Related news:\u00a0<a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.abl8213\" target=\"_blank\" rel=\"noopener\">ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Una proteina viene attratta da un componente chiave del farmaco. La ricerca \u00e8 stata pubblicata sulla rivista\u00a0Science Advances TGcom24 salute &#8211; 2 dicembre 2021 Un team di scienziati in Galles e negli Usa\u00a0ritiene di aver trovato &#8220;la causa scatenante&#8221; dei coaguli di\u00a0sangue estremamente rari che si creavano dopo la somministrazione del vaccino di AstraZeneca. Sotto &hellip;<\/p>","protected":false},"author":4,"featured_media":56002,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[39],"class_list":["post-61359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-vaccini"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/61359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=61359"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/61359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/56002"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=61359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=61359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=61359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}